Your browser doesn't support javascript.
loading
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
Connolly, Roisin M; Leal, Jeffrey P; Solnes, Lilja; Huang, Chiung-Yu; Carpenter, Ashley; Gaffney, Katy; Abramson, Vandana; Carey, Lisa A; Liu, Minetta C; Rimawi, Mothaffar; Specht, Jennifer; Storniolo, Anna Maria; Valero, Vicente; Vaklavas, Christos; Krop, Ian E; Winer, Eric P; Camp, Melissa; Miller, Robert S; Wolff, Antonio C; Cimino-Mathews, Ashley; Park, Ben H; Wahl, Richard L; Stearns, Vered.
Afiliação
  • Connolly RM; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Leal JP; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Solnes L; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Huang CY; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Carpenter A; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Gaffney K; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Abramson V; 2 Vanderbilt University, Nashville, TN.
  • Carey LA; 3 University of North Carolina, Chapel Hill, NC.
  • Liu MC; 4 Mayo Clinic, Rochester, MN.
  • Rimawi M; 5 Baylor College of Medicine, Houston, TX.
  • Specht J; 6 University of Washington, Seattle, WA.
  • Storniolo AM; 7 Indiana University, Indianapolis, IN.
  • Valero V; 8 The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Vaklavas C; 9 University of Alabama at Birmingham, Birmingham, AL.
  • Krop IE; 10 Dana-Farber Cancer Institute, Boston, MA.
  • Winer EP; 10 Dana-Farber Cancer Institute, Boston, MA.
  • Camp M; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Miller RS; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Wolff AC; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Cimino-Mathews A; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Park BH; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Wahl RL; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
  • Stearns V; 1 Johns Hopkins University School of Medicine, Baltimore, MD.
J Clin Oncol ; 37(9): 714-722, 2019 03 20.
Article em En | MEDLINE | ID: mdl-30721110
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Terapia Neoadjuvante / Anticorpos Monoclonais Humanizados / Trastuzumab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Moldávia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Terapia Neoadjuvante / Anticorpos Monoclonais Humanizados / Trastuzumab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Moldávia País de publicação: Estados Unidos